Brexpiprazole is a new atypical antipsychotic for schizophrenia management and as adjunct
in major depressive disorder (MDD). We searched randomized controlled trials (RCT) to …

Importance Quetiapine has been associated with increased risk of type 2 diabetes when
used in medium or high doses for the treatment of severe mental disorders. It is not known …

Abstract Background Clinical practice guidelines (CPGs) recommend the monitoring of
somatic parameters in patients treated with antipsychotic drugs in order to detect adverse …

The life expectancy of patients with a mental disorder, both common and severe, is between
10-30 years shorter compared to the general population. Approximately 60% of this …

Cariprazine is a new atypical antipsychotic for management of schizophrenia and bipolar
disorder. This article examines the role of cariprazine, a partial D2 and D3 receptor agonist …

JAMA Network Open Page 1 10/3/23, 7:18 Association of Low-Dose Quetiapine and
Diabetes - PMC https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105749/?report=printable 1/20 …

Brexpiprazole is a new atypical antipsychotic used for the management of psychiatric
conditions including schizophrenia and is associated with fewer extrapyramidal side effects …

Clinicians are not consistently following metabolic screening guidelines for second-
generation antipsychotics (SGAs). Although consensus guidelines have been in place since …